AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

The U.S. healthcare system is complex. For AbbVie to lead the industry in this environment, it is vital that our US Market Access (USMAx) Pipeline Team thoroughly comprehend the current and future state of the evolving U.S. healthcare space and market access channels. 

The Director, USMAx Pipeline is an individual contributor who will lead U.S. market access strategy development for early pipeline priority assets within the assigned AbbVie franchise. This Director will be directly responsible for integrating an understanding of the complex U.S. health system and the needs and requirements of U.S. payers into early asset development and bring the voice of U.S. payers to our early drug development process. The ideal candidate will have a strong understanding of U.S. private and public payer segments, pharmacy and medical benefit reimbursement, buy and bill models, and the IRA. The candidate must be able to think strategically and critically, build strong and trusting relationships for cross-functional influence, and demonstrate strong executive presence in order to represent U.S. Market Access effectively in pipeline governance and business development discussions.

The Director will work closely with cross-functional colleagues in Pipeline Commercialization Strategy (PCS) and Commercial Leadership to determine USMAx project and deliverable prioritization and will lead the delivery of these projects. This role will ensure integration within the AbbVie Pipeline Commercialization Model, including co-leadership of the Value and Access Teams (VATs) with International Market Access (IMAP) colleagues, and will lead the creation of US EIVPs (Early Integrated Value Propositions) and Integrated Access Strategies (IAS). The Director will also participate in Asset Strategy Team discussions and provide leadership within other Pipeline Commercialization Model teams as needed (IEST). The ideal candidate will bring a proven track record of supporting a positive team culture, leading by example, strong cross-functional stakeholder alignment, and an understanding of the AbbVie Pipeline Commercialization Model.

Specific Accountabilities Include:

• Responsible and accountable for the access point of view and creation of Integrated Asset Strategies, Early Integrated Value Propositions and Disease Area Strategies within the AbbVie Portfolio.
• Collaborate with teams across BUs, PCS, IMAP, Medical, HEOR, CBSO, IRA, R&D, and others to ensure the value drivers of USMAx decision makers are incorporated into pipeline commercialization strategies.
• Inform clinical development programs so that endpoints and evidence generation plans (i.e., clinical, economic, and humanistic outcomes) support optimized patient access for new and novel therapies
• Ensure project resource needs are met; secure and allocate budgets across asset assignments to meet critical enterprise goals for pipeline assets.
• Ensure that deep USMAx insights are embedded in all early pipeline strategies to support optimal asset development through the 1-7-5 model.
• Initiate market shaping in a timely fashion, ensuring a smooth hand-off to Directors, USMAx Marketing, for U.S. launch readiness preparation.
• Provide strong asset leadership, serving as the primary point of contact for USMAx Pipeline stakeholders aligned to that asset and disease area.
• Act as a critical partner to key internal stakeholders who drive early pipeline strategy, including U.S. Commercial Leadership, Asset Strategy Leadership, Pipeline Commercial Strategy Leadership, Medical Affairs/HEOR, and International Market Access and Pricing.
• Represent USMAx Early Pipeline as a subject matter expert at governance reviews as needed (e.g., TASC, LMG, DRC, etc.).
• Contribute critical strategic thinking to inform access and pricing assumptions to create accurate, market-driven LRP assumptions for pipeline assets and business development (as assigned).
• Serve as pipeline lead, accountable for USMAx financial LRP and strategic LRP assumptions for all assigned assets.
• Work closely across USMAx teams and stay up to date on channel dynamics and priorities.
• Partner with IRA and cross-strategy teams to ensure optimal asset planning and inform strategic planning and decision-making.
• Demonstrate enterprise mindset and leadership, act as a role model and example across the team

• 2+ years of US market access experience preferred
• Proven ability to influence without authority and navigate complex and ambiguous organizational dynamics with sound decision-making.
• Subject matter expertise relevant to commercial and government payers is required.
• U.S. market access experience across several roles is preferred.
• Expertise in developing compelling early payer value propositions preferred.
• Experience leading primary and secondary payer research projects to inform payer insights, market value drivers, and channel strategies.
• Knowledge of government contracting, acquisition trends, and role of market access stakeholders across the patient journey
• Experience in pipeline development and/or market access launches, ideally in the assigned disease area.
• Experience with pharmacy and medical benefit products, pricing, and GtN (Gross-to-Net) influences as well as differing acquisition models (e.g., Buy & Bill, DTP).
• Previous disease area experience and knowledge of competitive environment as well as and clinical trial endpoints is preferred.
• Strong strategic thinking, communication skills, and executive presence are required.
• Financial acumen and ability to comprehend complex planning scenarios required.

Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law: ​

• The compensation range described below is the range of possible base pay compensation that the Company believes in good faith it will pay for this role at the time of this posting based on the job grade for this position. Individual compensation paid within this range will depend on many factors including geographic location, and we may ultimately pay more or less than the posted range. This range may be modified in the future. ​

• We offer a comprehensive package of benefits including paid time off (vacation, holidays, sick), medical/dental/vision insurance and 401(k) to eligible employees.​

• This job is eligible to participate in our short-term incentive programs. ​

Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law. 

AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community.  Equal Opportunity Employer/Veterans/Disabled. 

US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html

US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:

https://www.abbvie.com/join-us/reasonable-accommodations.html